Specific Biologics' mission is to develop novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
We are actively developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. This technology is designed to better exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.
Location: Canada, Ontario, Toronto
Employees: 1-10
Founded date: 2017
Investors 3
| Date | Name | Website |
| 19.12.2021 | Lumira Ven... | lumiravent... |
| - | Canadian T... | ctaconnect... |
| - | Creative D... | creativede... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 16.10.2023 | Specific Biologics Receives Additional Investment | Specific Biologics, a Toronto, Canada-based early-stage biotechnology company, received an additiona... | finsmes.co... |
| 16.12.2021 | Specific Biologics Closes Seed Financing with Industry Leade... | Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Duala... | admarebio.... |